Vision Retirement’s Corcept Therapeutics CORT Stock Holding History

Vision Retirement’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.5K	Hold	500	–	–	0.01%	242
2026 Q1	$20.2K	Hold	500	–	–	0.01%	324
2025 Q4	$17.4K	Buy	+500	New	+$39.3K	﹤0.01%	346

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vision Retirement's CORT Position: Q2 2026 in Review

Vision Retirement held its Corcept Therapeutics (CORT) position steady in Q2 2026 at 500 shares worth $43.5K. The position accounts for 0.01% of the portfolio, ranked #242.

Vision Retirement first reported a position in CORT in Q4 2025 and has held it in 3 quarters since. 398 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Vision Retirement held 500 shares of Corcept Therapeutics worth $43.5K as of Q2 2026.
Vision Retirement left its Corcept Therapeutics share count unchanged in Q2 2026.
Corcept Therapeutics made up 0.01% of Vision Retirement's portfolio in Q2 2026, its #242 holding.
Vision Retirement first reported a position in Corcept Therapeutics in Q4 2025 and has held it in 3 quarters since.
398 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Vision Retirement's 13F filing for Q2 2026, filed 21 Jul 2026.